ProPhase Labs Inc (NASDAQ: PRPH) stock suffered a major decline of -10.7% on 7/5/24. The shares closed at $3.24. Moreover, trading volume in this decline was exceptionally high at 218% of normal. The stock has performed in line with the market over the last nine months and has declined -23.9% during the last week.
Current PriceTarget Research Rating
PRPH’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be a modest Value Builder.
ProPhase Labs has a current Value Trend Rating of B (Positive). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. ProPhase Labs has a neutral Power Rating of 53 but a good Appreciation Score of 74, producing the Positive Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment